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ABSTRACT
Objectives: Jaundice is a main problem in the early neonatal period and it is suggested that there is a positive correlation between plasma ionized 
Mg levels and severity of hyperbilirubinemia in newborn. The aim of this study is to explore the association and to evaluate and interpret its clinical 
significance as well as to observe the effect of phototherapy on serum magnesium and bilirubin level in the cases of neonatal jaundice.
Methods: A prospective study was conducted on 60 neonates in neonatology unit, pediatrics department, all of them suffering from neonatal 
jaundice >6-20 mg/dl serum bilirubin level. Blood samples for determination of plasma Mg (total and ionized) and serum bilirubin levels were 
obtained from infants in 4, 6, and 10 days, and statistical analysis was performed.
Results: There was statistically significant difference in relation to ionized magnesium level before phototherapy mean±SD (0.57±0.03 mg/dl) and 
group after phototherapy mean±SD (0.54±0.02, p<0.05) correspondingly bilirubin level before phototherapy mean±SD (13.9±3 mg/dl) and after 
phototherapy (9±3.4 mg/dl, p<0.05).
Conclusion: From this prospective study, it is concluded that phototherapy decrease serum Mg level as it decreases serum bilirubin level, and therefore 
there is a positive relation between serum bilirubin and serum Mg levels and rising of magnesium during hyperbilirubinemia may be a physiological 
compensatory mechanism that counter toxic effect of bilirubin.
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INTRODUCTION
Jaundice is the frequently prevalent occurrence and serious medical 
consideration in neonates. The clinical symptoms of yellowishness of the 
skin, nail bed, and sclera in neonates with jaundice are the consequence 
of deposition of unconjugated bilirubin [1]. Newborns appear jaundiced 
when it is >7 mg/dl, between one-quarter to half percentage of all 
term and higher than those percentage is prevalent in infants born 
before term develops clinical jaundice. Furthermore, 6.1% of well-term 
newborns have maximal serum bilirubin level over 12.9 mg/dl [1].
Magnesium is the fourth most plentiful cation in the body and its greater 
part is stored in intracellular compartment. However, the extracellular 
concentrations of magnesium that is of interest to the clinician due to 
its association in manifestation. The major organs system concerned 
with magnesium homeostasis are the gastrointestinal, skeletal, and 
renal, but the regulators influencing these organs at the cellular level 
yet unsettled. Hypermagnesemia is rarest and is observed mostly in 
those with renal failure and in geriatric, and documentation is that 
there is a positive correlation between plasma ionized Mg levels and 
severity of hyperbilirubinemia in newborn [2-4].
Therefore, measurement of ionized magnesium (IMg) provides 
an accurate assessment of the unbound form of Mg, which is the 
biologically active form and is most insightful [5,6].
METHODS
This study was conducted on 60 full-term jaundice neonates with 
pathological hyperbilirubinemia over a period from August 2011 to 
August 2013 in neonatology unit, pediatrics department.
Inclusion criteria
Full-term neonates with pathological hyperbilirubinemia (neonatal 
hyperbilirubinemia was diagnosed when newborn infant has a peak 
bilirubin level from 7 to 20 mg/dl in serum within 10 days of birth in 
terms) and having unconjugated bilirubin/total bilirubin ≥80%.
Exclusion criteria
Direct bilirubin >20% - Exchange transfusion cases. Neonates 
with cephalohematoma, congenital malformation, inborn errors of 
metabolism, sepsis or whose mother was antenatally administered 
magnesium sulfate at any time during gestation. Hemolytic 
hyperbilirubinemia. All parents or guardians of neonates gave a written 
informed consent to participate in this study. The study was approved 
by the Ethics Committee of Faculty of Medicine.
Methods
A total of 40 males and 20 females neonate were study subjects, 
blood samples for determination of plasma Mg and serum bilirubin 
levels were obtained from infants during veinpuncture and then 
following:
Laboratory investigations were performed:
• Complete blood count
• Blood group and subgroup typing and Rh of the mother and infant
• Serum total and direct bilirubin level
• Serum magnesium level (total and ionized).
Plasma magnesium levels were measured spectrophotometrically 
using ready for use kit.
Laboratory investigations were applied including total serum bilirubin 
before and 72 hrs after phototherapy, total serum magnesium before 
and after 72 hrs after starting of phototherapy.
Table 1 shows the bilirubin level before and after phototherapy in the 
studied neonates. There was statistically decrease in bilirubin level 
between group before phototherapy and after phototherapy.
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Table 2 shows total magnesium level before and after phototherapy in 
the studied neonates. There was statistically significant difference in 
relation to magnesium level between group of before phototherapy and 
after phototherapy.
Table 3 shows ionized magnesium level before and after phototherapy 
in the studied neonates. There was statistically significant difference 
in relation to ionized magnesium level between group of before 
phototherapy and after phototherapy.
DISCUSSION
Preterm newborns have a common hyperbilirubinemia in the early 
neonatal period [1].
One of the effective and safe therapy used for babies whose level is 
getting high is phototherapy potential adverse effects of which is usually 
minimal if appropriate precautions are taken, and there is no evidence 
to suggest that phototherapy has any adverse long-term effect [1].
Our study showed that there was statistically significant difference 
in relation to bilirubin level and a significant difference in relation 
to magnesium level between group of before phototherapy and after 
phototherapy.
In agreement with our study, Sarici et al. [6] found a positive correlation 
between ionized Mg and the severity of hyperbilirubinemia in full-term 
newborns with neonatal jaundice.
Mehta and Petrova [7] suggested the possibility of a neuroprotective 
role or a compensatory mechanism in plasma ionized Mg increase 
against emerging toxicity risk of increasing serum bilirubin values and 
this agreed with our result.
Bhat et al. [8] and Gathwala et al. [9] concluded that postnatal 
magnesium sulfate treatment had a neuroprotective effect that protects 
brain from bilirubin toxicity, and this explain our results.
Mohsen et al. [10] concluded that increase in plasma IMg may be due 
to extracellular movement of Mg, a principally intracellular ion, ensuing 
from generalized cellular damage and disruption even incorporating 
to neurons and erythrocytes. This increase has neuroprotective role 
against promising toxicity risk of escalating serum bilirubin levels, and 
this may be the compensatory indigenous grounds for our results.
CONCLUSION
Hyperbilirubinemic state raises risk of potential bilirubin toxicity 
to gray matter of brain or cardiocyte, to compensate this effects 
extracellular movement of Mg, resulting from generalized cellular 
injury including neurons and erythrocytes occurs with possibility of a 
neuro and cardioprotective effect.
Phototherapy proportionately reduces bilirubin correspondingly to 
IMg suggesting positive correlation between serum bilirubin and 
serum Mg levels. The value of Mg treatment in the therapy of neonatal 
hyperbilirubinemia deserves further studies.
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Mean±SD 13.9±3 9±3.4 6.779 <0.001*
Range 10‑18.7 mg/dl 6-14 mg/dl
*p value is significant if<0.05, SD: Standard deviation
Table 2: Total magnesium level before and after phototherapy in 









Mean±SD 2.3±0.7 2.0±0.5 4.134 0.002*
Range 1.82‑3.9 mg/dl 1.4‑2.78 mg/dl
*p value is significant if<0.05, SD: Standard deviation
Table 3: Ionized magnesium level before and after phototherapy 









Mean±SD 0.57±0.03 0.54±0.02 3.12 0.0035*
Range 0.53-0.61 mg/dl 0.50‑0.58 mg/dl
*p value is significant if<0.05, SD: Standard deviation
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